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Ko B, Kamsteeg E, Cooke LL, Moddes LN, Deen PM, Hoover RS.
RasGRP1 stimulation enhances ubiquitination and endocytosis of the
sodium-chloride cotransporter. Am J Physiol Renal Physiol 299: F300–F309,
2010. First published April 14, 2010; doi:10.1152/ajprenal.00441.2009.—
The sodium-chloride cotransporter (NCC) is the principal salt-absorp-
tive pathway in the distal convoluted tubule. Recently, we described
a novel pathway of NCC regulation in which phorbol esters (PE)
stimulate Ras guanyl-releasing protein 1 (RasGRP1), triggering a
cascade ultimately activating ERK1/2 MAPK and decreasing NCC
cell surface expression (Ko B, Joshi LM, Cooke LL, Vazquez N,
Musch MW, Hebert SC, Gamba G, Hoover RS. Proc Natl Acad Sci
USA 104: 20120–20125, 2007). Little is known about the mechanisms
which underlie these effects on NCC activity. Regulation of NCC via
changes in NCC surface expression has been reported, but endocytosis
of NCC has not been demonstrated. In this study, utilizing biotinyla-
tion, internalization assays, and a dynamin dominant-negative con-
struct, we demonstrate that the regulation of NCC by PE occurs via an
enhancement in internalization of NCC and is dynamin dependent. In
addition, immunoprecipitation of NCC and subsequent immunoblot-
ting for ubiquitin showed increased ubiquitination of NCC with
phorbol ester treatment. MEK1/2 inhibitors and gene silencing of
RasGRP1 indicated that this effect was dependent on RasGRP1 and
ERK1/2 activation. Inhibition of ubiquitination prevents any PE-
mediated decrease in NCC surface expression as measured by bioti-
nylation or NCC activity as measured by radiotracer uptake. These
findings confirmed that the PE effect on NCC is mediated by endo-
cytosis of NCC. Furthermore, ubiquitination of NCC is essential for
this process and this ubiquitination is dependent upon RasGRP1-
mediated ERK1/2 activation.
ubiquitin; ERK1/2; MAPK
THE THIAZIDE-SENSITIVE sodium-chloride cotransporter (NCC),
encoded by the SLC12A3 gene, in the distal convoluted tubule
(DCT) of the kidney plays a key role in renal salt handling and
blood pressure regulation. Residing in the DCT, NCC is
responsible for the reabsorption of 5–10% of filtered sodium
and chloride in the kidney (7). The cotransporter’s importance
in sodium balance, and therefore blood pressure regulation, is
demonstrated not only by the efficacy of thiazide diuretics but
also by the hypotension seen with loss of NCC function
(Gitelman’s syndrome) and the hypertension seen with in-
creases in NCC activity (familial hyperkalemic hypertension or
FHHt) (19, 27, 39). Recently, we identified a regulatory path-
way for NCC, demonstrating that phorbol esters (PE) regulate
NCC activity (12). Importantly, PE act as functional analogs of
diacylglycerol (DAG) and do not act on NCC in this system via
protein kinase C but instead mediate activation of Ras guanyl-
releasing protein 1 (RasGRP1), ultimately leading to increased
ERK1/2 MAPK activation. Following activation by DAG,
RasGRP1 activates the small G protein Ras (specifically the
isoform H-Ras in this system) by causing release of GDP from
Ras. Ras then binds and is activated by GTP. Ras activates Raf,
the first kinase in the ERK1/2 MAPK pathway. Raf then
phosphorylates and activates MEK1/2, which in turn phosphor-
ylates and activates ERK1/2. Activation of the Ras-MEK-
ERK1/2 MAPK cascade by PE/RasGRP1 is necessary for the
decreases in NCC activity seen with PE administration (12).
While the functional effect on NCC activity by PE correlates
with a decrease in the amount of NCC expressed on the cell
surface, the mechanisms by which this may occur are not
known (12). Investigators exploring the modulation of NCC by
other agents have found evidence that forward trafficking
appears to be regulated (3, 9, 33). Whole animal studies have
demonstrated the existence of a subapical pool of NCC and
have shown a redistribution of NCC from the cell surface to
this subapical pool under inhibition of the angiotensin-convert-
ing enzyme, but it is not clear whether this redistribution
represents decreased forward trafficking or increased endocy-
tosis (23, 24). Details of how these cell-trafficking events occur
need to be further explored.
The role of ERK1/2 activation in the DAG/PE effect on
NCC activity is of particular interest as ERK1/2 activation has
been linked to ubiquitination of a number of proteins, including
the epithelial sodium channel (ENaC) (1a, 13, 15, 18, 26, 28).
Ubiquitin is an 8-kDa highly conserved protein that covalently
attaches to lysine residues of target proteins either singly
(monoubiquitination) or in polymerized chains (polyubiquiti-
nation). This attachment can tag a protein for endocytosis
and/or degradation and is accomplished via the enzymes E1,
E2, and E3, which act to transfer ubiquitin molecules to the
target protein. In some systems, regulating the ubiquitination of
a protein allows for modulation of that protein’s endocytosis
and/or degradation. ERK1/2 MAPK has clearly been shown to
play a role in the regulation of ubiquitination and subsequent
degradation in a variety of settings, from the regulation of
ENaC to programmed cell death (1a, 13, 15, 18, 26, 28).
We therefore theorized a potential role for ERK1/2 MAPK
activation in regulating ubiquitination and sought to assess the
role of ubiquitination in cell-trafficking events that result in
decreased NCC surface expression. In this study, using both a
mammalian cell model with native NCC function and a heter-
ologous mammalian expression system, we demonstrate that
the regulation of NCC by DAG/PE occurs due to a decrease in
NCC surface expression via enhanced, dynamin-dependent
endocytosis. Furthermore, we show that ubiquitination of NCC
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is essential for this process and that this ubiquitination is
dependent upon RasGRP1-mediated ERK1/2 activation.
MATERIALS AND METHODS
Materials. Materials were purchased from Sigma-Aldrich (St.
Louis, MO) unless stated otherwise. The mouse DCT (mDCT) cells
were a gift from Dr. Peter Friedman. The K44A dynamin construct
was a gift from Dr. Eugene Chang. The Madin-Darby canine kidney
(MDCK) cell lines expressing Flag-NCC were a gift from Dr. René
Bindels. The NCC antibody was a gift from Dr. Mark Knepper.
Cell culture and treatments. mDCT cells were plated on cell culture
dishes and grown in growth medium containing a 50:50 mix of
DMEM/F12, 5% heat-inactivated fetal bovine serum, and 1% peni-
cillin/streptomycin/neomycin (P/S/N) at 37°C. Experiments were con-
ducted when the cells reached 90–95% confluence. MDCK cell
culture, immunocytochemistry, and the collection of images were
performed as described elsewhere (5). Cells were treated with TPA
(107 M) in culture medium where indicated and for the indicated
time intervals.
Assessment of NCC function in mDCT cells. mDCT cells were
seeded in 12-well plates and prepared as described. The cells were
then incubated in a serum-free, preuptake medium (130 mM Na
gluconate, 2 mM K gluconate, 1.0 mM Ca gluconate, 1 mM Mg
gluconate, 5 mM HEPES/Tris pH 7.4, 1 mM amiloride, 0.1 mM
bumetanide) for 30 min. For studies examining forward trafficking,
the cells were incubated with 10 M befreldin A (BFA) for 1 h.
During this time period, the cells were treated with the various agents
being studied [100 nM TPA for 15 min and either 10 nM U0126 or
vehicle (DMSO) for 15 min]. The medium was then changed to a
22Na-containing medium (140 mM NaCl, 1 mM CaCl, 1 mM MgCl,
5 mM HEPES/Tris, pH 7.4, 1 mM amiloride, 0.1 mM bumetanide, 0.1
mM benzamil, 1 mM ouabain, and 1 Ci/ml of 22Na) with or
without thiazide (0.1 mM metolazone) and incubated for 20 min.
Tracer uptake was then stopped via washes with ice-cold wash buffer.
Cells were subsequently lysed with 0.1% SDS. Radioactivity was
measured via liquid scintillation, and protein concentrations of the
lysates were determined [bicinchoninic acid (BCA) protein assay,
Pierce, Rockford, IL]. Uptakes were normalized to nanomoles per
milligram. Thiazide-sensitive uptake was given by the difference of
the uptakes with and without thiazide.
Cell surface biotinylation. mDCT cells were incubated in a pre-
uptake medium (detailed above) for 15 min. Then, 100 nM TPA or
DMSO vehicle was added to the medium, and the cells were incubated
for 15 more min. The preuptake medium was removed and uptake
medium (as above, without 22Na) was added, and the cells were
incubated for 20 min. For studies examining forward trafficking, the
cells were incubated with 10 M BFA for 1 h. The cells were washed
with PBS, and cell surface proteins were labeled with sulfo-NHS-SS-
biotin (Pierce) in PBS for 30 min at 4°C. The reaction was quenched
by adding 500 l of the quenching solution (Pierce). The cells were
harvested, lysed using lysis buffer containing protease inhibitor, and
homogenized by sonication on ice. The cell lysates were centrifuged
briefly, and the supernatant was collected. Eighty microliters of the
supernatant from each group was stored separately at 80°C. Biotin-
ylated proteins in the cell lysates were isolated by incubating with
NeutrAvidin gel (Pierce) for 60 min at room temperature. The labeled
proteins were eluted in SDS-PAGE sample buffer containing 50 mM
DTT. Protein concentrations were determined by using a BCA protein
assay kit (Pierce). The eluted proteins and the cell lysates were
immunoblotted with polyclonal anti NCC antibody. For each group,
80 g of total protein from the cell lysate was loaded along with 30
l of biotinylated protein from the DMSO control group and the
proportionate volume from the rest of the biotinylated protein groups.
MDCK cells were grown to confluence on six-well filters, treated as
wanted, placed on ice, and washed twice with ice-cold PBS, 1 mM
CaCl2 and 0.1 mM MgCl2 (PBS-CM) as previously described (5).
Surface proteins were biotinylated twice for 20 min each with freshly
prepared ice-cold 1.5 mg/ml sulfo-NHS-SS-biotin (Pierce) in 10 mM
tri-ethanolamine (pH  8.9), 2 mM CaCl2, and 125 mM NaCl. Cells
were subjected to gentle rocking to ensure uniform mixing during the
biotinylation reactions. Then, excess biotin was quenched for 5 min
with ice-cold 50 mM NH4Cl in PBS-CM, and the cells were washed
three times with ice-cold PBS-CM. For biotinylation experiments,
cells were lysed in 1 ml of lysis buffer [1% Triton X-100, 150 mM
NaCl, 5 mM EDTA, 50 mM Tris (pH  7.5)] for 30 min at room
temperature.
Internalization experiments. For internalization experiments, sur-
face proteins were biotinylated as above before undergoing the inter-
nalization protocol (11). Cells were then warmed by reheating in a
37°C incubator for 5 min (to minimize thermal shock) before incu-
bation with prewarmed culture medium. Cells were then treated with
the agents of interest. Next, the cells were returned to ice, washed
three times with ice-cold PBS-CM, treated three times for 20 min each
with ice-cold 100 mM 2-sodium mercaptoethanesulfonic acid
(MesNa) in 100 mM NaCl, 1 mM EDTA, 50 mM Tris (pH 8.6), and
0.2% BSA. Excess MesNa was quenched for 10 min with ice-cold 120
mM iodoacetic acid in PBS-CM, and cells were lysed as for biotiny-
lation. Subsequently, all lysates were precleared by centrifugation at
14,000 g and incubated with 30-l equivalents of prewashed strepta-
vidin-conjugated beads (Pierce) for 16 h. Finally, the beads were
washed twice with high-salt buffer [500 mM NaCl, 5 mM EDTA, 50
mM Tris (pH 7.5), 0.1% Triton X-100], twice with lysis buffer, and
once with 10 mM Tris (pH  7.5) and resuspended in 30 l Laemmli
buffer.
Immunoblotting. For mDCT cells, a 7.5% polyacrylamide gel was
used. Proteins were transferred electrophoretically to polyvinylidene
difluoride membranes. After blocking with 3% BSA, the membranes
were probed with corresponding primary antibodies [ubiquitin (Cell
Signaling) 1:1,000, anti-RasGRP1 (Cell Signaling), dilution 1:200, or
anti-NCC (Knepper) dilution 1:50,000] overnight at 4°C. The blots
were washed in TBST. Signal detection for RasGRP1, NCC, and
ubiquitin was done using IRDye800 goat anti-mouse IgG antibody,
IRDye800 rabbit anti-goat IgG antibody, IRDye800 goat anti-rabbit,
and IRDye680 goat anti-mouse (dilution 1:10,000, Rockland Immu-
nochemicals) and subsequent scanning of the membrane by an Odys-
sey Infrared Imager. Intensity of the protein bands was analyzed by
using Odyssey Infrared Imaging Software (Li-Cor Biosciences). For
MDCK cells, PAGE and blotting, blocking, antibody incubation, and
chemiluminescence of the membranes were performed as described
(11). Ubiquitin (Zymed, San Francisco, CA) antibodies were diluted
1:250, followed by 1:10,000-diluted biotinylated anti-mouse IgG’s
(Jackson Laboratories) and by 1:8,000-diluted streptavidin-peroxi-
dase. Mouse Flag antibodies (Zymed) were diluted 1:1,000.
Immunocytochemistry. Essentially, immunocytochemistry and col-
lection of images were performed as described previously (5), except
that cells were not permeabilized with 1% Triton X-00 but with 1%
saponin. Mouse Flag antibodies were diluted 1:100.
Immunoprecipitation. MDCK cells were grown to confluence,
treated as indicated, lysed [1% Triton X-100, 150 mM NaCl, 25 mM
HEPES (pH  7.4), supplemented with protease inhibitors and 20
mM NEM] and spun down to remove nonsolubilized material. Fif-
teen-microliter equivalents of protein A-agarose were preincubated
with either rabbit FLAG antibodies in IPP500 [500 mM NaCl, 10 mM
Tris (pH  8.0), 0.1% NP-40, 0.1% Tween 20], rabbit antibodies to
RasGRP1 (Santa Cruz Biotechnology), or rabbit antibodies to NCC
and 0.1% BSA, and washed three times with IPP500. The precleared
lysates were incubated for 16 h at 4°C with the antibody-bound
protein A beads. The beads were washed three times with lysis buffer,
and proteins were eluted using 15 l Laemmli buffer.
Dominant-negative dynamin transfection. mDCT cells were grown
to 80% confluence in a medium containing a 50:50 mix of DMEM/
F12 plus 5% heat-inactivated FBS, and 1% P/S/N. The heme agglu-
tinin (HA)-K44A dynamin construct or wild-type dynamin was tran-
F301RasGRP1 ENHANCES UBIQUITINATION AND ENDOCYTOSIS OF NCC
AJP-Renal Physiol • VOL 299 • AUGUST 2010 • www.ajprenal.org
 o
n
 July 11, 2012
ajprenal.physiology.org
D
ow
nloaded from
 
siently transfected into these cells using GenePorter Transfection
Reagent per the manufacturer’s protocol (Genlantis). Confirmation of
transfection was achieved by immunoblotting using a rabbit anti-
dynamin antibody (1:1,000 dilution, Cell Signaling).
Gene silencing. mDCT cells were grown to 80% confluence in a
medium containing a 50:50 mix of DMEM/F12 plus 5% heat-inacti-
vated FBS, and 1% P/S/N. Small interfering (si) RNA specific for
RasGRP1 (Dharmacon) was transfected into these cells using Gene-
Silencer siRNA Transfection Reagent per the manufacturer’s protocol
(Genlantis). Nontargeting siRNA differing by a single base pair from
the siRNA for RasGRP1 (Dharmacon) was used as a control (1).
ERK1/2 phosphorylation assay. mDCT cells grown to 80% con-
fluence after transfection with siRNA were incubated for 30 min in a
preuptake medium. During this time period, the cells were treated
with 100 nM TPA for 15 min. Cells were subsequently lysed in 1 ml
of lysis buffer containing 50 mM Tris·HCl, pH 7.5, 150 mM NaCl, 1%
Nonidet P-40, 0.5% sodium deoxycholate, and 1 tablet of Complete
protease inhibitors (Roche). The lysates were homogenized by soni-
cation on ice. Protein determination and immunoblotting were then
performed as described above using antibodies for ohospho-ERK1/2
(1:1,000, Cell Signaling) and ERK1/2 (1:200, Santa Cruz Biotechnol-
ogy). Densitometry was then performed, and relative densitometry
was reported by expressing each group as a fraction of its phosphor-
ylated form over total ERK1/2. Controls were then normalized to 1.
Statistical analysis. Statistical analysis was performed using the
SigmaStat software package (Systat, San Jose, CA). Data was ana-
lyzed for statistical significance using ANOVA (Holm-Sidak). A
P value of 0.05 was taken as statistically significant.
RESULTS
PE enhance endocytosis of NCC. We previously demon-
strated that the reduction of NCC activity with DAG/PE
stimulation was tied to a decrease in NCC surface expression
(12). To assess the mechanism by which this occurs, we
performed internalization assays on mDCT cells. In this assay,
cell surface proteins are first biotinylated at 4°C before the cells
are rewarmed and treated with TPA. The cells are then treated
with MesNa, a cell-impermeable acid which cleaves the biotin-
protein attachments. Since MesNa is cell impermeable, any
remaining biotinylated protein represents internalized proteins.
This protocol is a well-established method for assessing inter-
nalization (5, 11, 21, 34). As shown in Fig. 1, treatment with
MesNa virtually eliminated surface-expressed NCC (control
with MesNa at time 0) compared with vehicle (control at time
0 without MesNa). Increased internalization of NCC with
exposure to TPA (100 nM) vs. control (vehicle, DMSO) was
evident as early as 10 min after exposure (P  0.01). Over this
time, total cellular NCC remained constant in both groups,
suggesting that NCC degradation does not occur in response to
PE in this time frame. These findings are consistent with
images obtained using MDCK cells stably transfected with
Flag-tagged NCC subjected to immunocytochemistry and con-
focal microscopy. These MDCK-Flag NCC cells were treated
with 100 nM TPA for 15 and 45 min before fixation and
immunocytochemistry. Subsequent confocal microscopy in
both the XY and XZ planes show decreased apical NCC surface
expression 15 and 45 min after treatment with TPA (Fig. 1B).
Dynamin is a GTPase critical for endocytosis, an effect
inhibited by the dominant-negative dynamin mutant K44A (4).
Therefore, to demonstrate that PE-induced NCC endocytosis is
dynamin dependent, mDCT cells were transfected with HA-
tagged dynamin dominant-negative construct to assess the
dynamin dependence of the DAG/PE effect. Mock transfected
cells behaved similarly to those observed in our previous
experiments, resulting in a 76  4% reduction in NCC surface
expression with TPA compared with control, but mDCT cells
expressing the dominant-negative dynamin showed no change
in NCC surface expression with TPA administration (P 0.05
vs. vehicle, Fig. 2). Cells transfected with wild-type dynamin
behave as control. Taken together, these data indicate that the
DAG/PE effect upon NCC occurs via enhancing dynamin-
dependent endocytosis of surface NCC.
PE do not affect forward trafficking of NCC. While these
data show that TPA clearly enhances endocytosis, NCC has
been shown in other systems to be regulated via affecting
Fig. 1. Internalization of sodium-chloride cotransporter (NCC) with TPA
treatment. A: mouse distal convoluted tubule (mDCT) cells were grown to
confluence, labeled with biotin at 4°C, then rewarmed at treated with 100 nM
TPA or vehicle for the indicated times. Then, remaining surface biotin was
stripped using mercaptoethanesulfonic acid (MesNa). Cells were lysed and
biotinylated (internalized) proteins were recovered using streptavidin-agarose
and immunoblotted for NCC. Densitometry is shown, normalized to total
cellular NCC (n  4). CM, time 0 control with MesNa; CN, time 0 control no
MesNa; C5, DMSO control 5 min; C10, DMSO control 10 min; C20, DMSO
control 20 min; T5, TPA 5 min; T10, TPA 10 min; T20, TPA 20 min. *P 
0.05 vs. control at similar time point. B: Madin-Darby canine kidney cells
(MDCK) cells expressing Flag-NCC were grown to confluence on permeable
supports, treated with TPA for 15 and 45 min (T15 and T45, respectively),
fixed, and subjected to immunofluorescence using Flag antibodies. Confocal
images were obtained in the XY and XZ planes.
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forward trafficking of NCC to the plasma membrane (3, 9, 33).
Therefore, we examined the ability of TPA to affect forward
trafficking of NCC. BFA (10 M) was used to inhibit for-
ward trafficking of NCC. BFA blocks transport of new proteins
from the endoplasmic reticulum/Golgi to the plasma mem-
brane. As shown in Fig. 3A, NCC surface expression decreased
by 24  3% over control after 1 h of BFA incubation,
indicating continued endocytosis with inhibition of exocytosis
(P 0.05). At 3 h, NCC surface expression decreased by 52
4% over control (Fig. 3A, P  0.05). This is consistent with
previously published reports of BFA inhibition of NCC for-
ward trafficking, which demonstrated an NCC surface half-life
Fig. 3. Role of forward trafficking in TPA effect on surface expression and
NCC activity. A: mDCT cells were grown to confluence, treated with 10 M
befreldin A (BFA) for 0, 1 (1H), or 3 h (3H) before labeling with biotin at 4°C.
Biotinylated (cell surface) proteins were recovered using streptavidin-agarose
and immunoblotted for NCC. NC, no biotin control. Accompanying densitom-
etry is shown (n  4). *P  0.05 compared with time 0. B: mDCT cells
prepared as above were treated with 10 M BFA or vehicle for 1 h before
treatment with 100 nM TPA. Cells were then labeled with biotin at 4°C.
Biotinylated (cell surface) proteins were recovered using streptavidin-agarose
and immunoblotted for NCC. C, vehicle; B, BFA alone; T, TPA alone; BT,
BFA plus TPA. Accompanying densitometry is shown (n  4). *P  0.05
compared with control. #P  0.05 compared with BFA group. C: mDCT cells
were grown to confluence, treated with BFA or vehicle for either 1 or 3 h, and
then treated with 100 nM TPA (T) or vehicle for 15 min. Cells were
subsequently incubated in uptake medium with 22Na and either vehicle or 1
mM metolazone. Radioactive uptake was determined as in MATERIALS AND
METHODS. Thiazide-sensitive uptake was calculated as the difference in radio-
tracer uptake between the metolazone-containing and the metolazone-free
groups. C, control, B1, BFA 1 h; B3, BFA 3 h; T, TPA; B1T, BFA 1 h plus
TPA; B3T, BFA 3 h plus TPA (n  4). *P  0.05 compared with control.
#P  0.05 compared with control, B1, or B3 (no statistical difference among
T, B1T, and B3T).
Fig. 2. NCC surface expression after TPA treatment in cells expressing K44A
dynamin. mDCT cells were grown to confluence, transfected with hemeagglu-
tinin-tagged with either wild-type (DW) or K44A (DN) dynamin as described,
then treated with 100 nM TPA (T) or vehicle (C) for 15 min before labeling
with biotin at 4°C. Biotinylated (cell surface) proteins were recovered using
streptavidin-agarose and immunoblotted for NCC. NC, no biotin control;
DWT, wild-type dynamin plus TPA; DNT, DN plus TPA. Accompanying
densitometry is shown (n  4). *P  0.05.
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of 3 h (33). NCC activity showed a similar decrease with
BFA treatment, 12.4 3.2% of control at 1 h and 45.3 1.3%
of control at 3 h (Fig. 3C, P  0.05). In mDCT cells treated
with a 1-h BFA incubation, TPA treatment essentially elimi-
nated NCC surface expression (Fig. 3B). This was similar to
TPA alone, indicating that TPA does not significantly act on
NCC by affecting forward trafficking (33). This is in contrast
to WNK4’s effect on NCC, which acts via inhibition of
forward trafficking (3, 9, 33). NCC activity was essentially
eliminated by TPA compared with control by TPA alone or in
groups treated with BFA for either 1 or 3 h (Fig. 3C, P 0.05)
There were no significant differences in surface expression
between the TPA alone and the two BFA- and TPA-treated
groups. This demonstrates that PE do not act on NCC via
forward trafficking but instead via enhanced endocytosis.
PE enhance ubiquitination of NCC. As previously dis-
cussed, we theorized that a potential signal for endocytosis of
NCC was ubiquitination. To investigate a possible role for
ubiquitin in mediating internalization of NCC in response to
DAG/PE, we assessed the ability of TPA to augment ubiquiti-
nation of NCC. mDCT cells were treated with 100 nM TPA for
varying time periods minutes before lysis and immunoprecipi-
tation. Immunoblotting showed a significant increase in ubi-
quitinated NCC by 10 min of TPA treatment and a nearly
fivefold increase in ubiquitinated NCC over control after 20
min of TPA treatment (P  0.01 by ANOVA, n  4, Fig. 4A).
Ubiquitination of NCC was also assessed in the MDCK Flag-
NCC cell line. These cells were treated with 100 nM TPA for
5 min, lysed, and immunoprecipitated with anti-FLAG anti-
body. Subsequent immunoblotting for ubiquitin clearly dem-
onstrated a band centered around 140 kDa, representing ubiq-
uitination of NCC (Fig. 4B). These data indicate that NCC is
ubiquitinated after treatment with the PE TPA.
Ubiquitination of NCC is dependent on RasGRP1-mediated
ERK1/2 activation. As we have previously demonstrated that
PE regulate NCC via RasGRP1 activation of Ras, Raf,
MEK1/2, and ultimately ERK1/2, presumably, DAG/PE act
via this pathway to enhance NCC ubiquitination. To test this
theory, we assessed the ability of TPA to enhance NCC
ubiquitination while inhibiting portions of the pathway. mDCT
cells were treated with 100 nM TPA for 15 min along with the
MEK1/2 inhibitor U0126. Subsequent lysis, immunoprecipita-
tion for NCC, and immunoblotting for ubiquitin demonstrated
that while TPA alone results in a fivefold increase in ubiquiti-
nation (P  0.01 by ANOVA, n  4), the presence of a
MEK1/2 inhibitor prevents TPA-induced enhancement in
ubiquitination compared with either vehicle or U0126 alone
(Fig. 5A).
To verify the involvement of RasGRP1 in this process,
mDCT cells were transfected with siRNA specific for RasGRP1.
Cells treated in this manner were again treated with TPA and
assayed for NCC ubiquitination as above. Cells transfected
with nonspecific siRNA continued to demonstrate a nearly
fivefold increase in ubiquitinated NCC (P  0.01). A
94 5% reduction in RasGRP1 expression was achieved (Fig.
5B, P  0.05 compared with transfection with nontargeting
siRNA), and in these cells TPA did not have an effect on
ubiquitination of NCC compared with cells transfected with
nontargeting siRNA (Fig. 5A). These data indicate that TPA’s
ability to enhance NCC ubiquitination is dependent upon
activation of RasGRP1 and ERK1/2.
Inhibition of ubiquitination by an E1 inhibitor does not
affect ERK1/2 activation by TPA. To directly assess the role of
NCC ubiquitination in DAG/PE regulation of NCC, we utilized
a chemical inhibitor of ubiquitination, 4[4-(5-Nitro-furan-2-
ylmethylene)-3,4-dioxo-pyrazolidin-1-yl]-benzoic acid ethyl
ester (UBEI-41). UBEI-41 is a benzoic acid ethyl ester that
inhibits the action of the E1 enzyme, inhibiting ubiquitination
by preventing ubiquitin attachment (42). Incubation of mDCT
cells with 50 M UBEI-41 for 15 min eliminates ubiquitina-
tion of NCC in response to TPA (Fig. 6A). UBEI-41 had no
effect on ERK1/2 activation by TPA, with the combination of
TPA and UBEI-41 increasing ERK1/2 phosphorylation by 204
9 compared with 205 6% for TPA alone (P 0.05 for either
vs. vehicle by ANOVA, n  4, Fig. 6B). Therefore, UBEI-41
effectively inhibits ubiquitination of NCC but has no effect on
ERK1/2 activation by PE. Since RasGRP1 and ERK1/2 acti-
vation is necessary for TPA to enhance the ubiquitination of
NCC and inhibition of ubiquitination has no effect on ERK1/2
activation, this demonstrates that ERK1/2 phosphorylation and
activation lie upstream of ubiquitination of NCC.
Fig. 4. Ubiquitination of NCC after TPA treatment. A: mDCT cells were grown
to confluence, treated with 100 nM TPA (T) or vehicle (DMSO, C) for the
indicated times before lysis in RIPA buffer. NCC was then immunoprecipi-
tated using NCC antibodies before immunoblotting with anti-ubiquitin or
anti-NCC antibodies. Accompanying densitometry is shown (n  4). *P 
0.01. B: MDCK cells stably expressing FLAG-tagged NCC were grown to
confluence, treated for 5 min with (T) or without (C) TPA and lysed. The
transporters were immunoprecipitated using rabbit FLAG antibodies (IP:Flag),
and the immunoprecipitates were immunoblotted for ubiquitin (IB:Ub) or Flag
(IB:Flag). Marker bands are indicated on the left by their molecular weights (in
kDa).
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Inhibition of ubiquitination prevents effect of TPA on NCC
activity. To determine whether ubiquitination of NCC was
necessary for PE to modulate NCC surface expression and
activity, the ubiquitin inhibitor UBEI-41 was used. In mDCT
cells treated with TPA and biotinylated as described previ-
ously, the addition of UBEI-41 prevented the decrease in NCC
surface expression seen with TPA alone (unchanged from
baseline for TPA and UBEI-41 vs. 73  4% decrease from
baseline for TPA alone, Fig. 7A).
The impact of ubiquitination upon NCC function was then
assessed by measuring NCC activity by a 22Na radiotracer
uptake assay in the presence of 50 M UBEI-41. Treatment
with UBEI-41 for 15 min did not significantly alter the baseline
Fig. 5. NCC ubiquitination with TPA treatment with inhibition of the Ras
guanyl-releasing protein 1 (RasGRP1) ERK1/2 pathway. A: mDCT cells were
grown to confluence and treated with 10 nM U0126 (U) or vehicle (DMSO, C).
Cells were then treated with 100 nM TPA (T) or vehicle (DMSO, C) for 15 min
before lysis in RIPA buffer. NCC was then immunoprecipitated using NCC
antibodies before immunoblotting with anti-ubiquitin (Ub) or anti-NCC anti-
bodies (NCC). TU, TPA plus U0126 group. Accompanying densitometry is
shown (n  4). *P  0.01. B: mDCT cells were grown to confluence and
transfected with siRNA for RasGRP1 (S) or nontargeting small interfering (si)
RNA (N) as described. Suppression of RasGRP1 expression is shown in
immunoblot (P  0.05, n  4). Cells were then treated with 100 nM TPA (T)
or vehicle (DMSO, C) for 15 min before lysis in RIPA buffer. NCC was then
immunoprecipitated before immunoblotting with anti-ubiquitin or anti-NCC
antibodies as above. TS, TPAsiRNA for RasGRP1. Accompanying densi-
tometry is shown (n  4). *P  0.05.
Fig. 6. Inhibition of ubiquitination does not affect TPA-mediated ERK1/2
phosphorylation A: mDCT cells were grown to confluence, treated with 100
nM TPA (T) in the presence or absence of UBEI-41 (U) for 15 min before lysis
in RIPA buffer. TU, TPAUBEI-41. NCC was then immunoprecipitated using
NCC antibodies before immunoblotting with anti-ubiquitin or anti-NCC anti-
bodies; n 4. B: cells treated as described in A were lysed and immunoblotted
for phospho-ERK1/2 and ERK1/2; n  4. C, control. *P  0.05.
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activity of NCC (Fig. 7B). However, UBEI-41 did significantly
alter the response to TPA, with TPA and UBEI-41 in combi-
nation causing no change in NCC activity while TPA alone
resulted in a 87  8% decrease, indicating that ubiquitination
of NCC is essential in decreasing NCC activity (P  0.01 vs.
vehicle, n  6). These data show that stimulation of NCC
ubiquitination is essential for decreases in NCC surface ex-
pression and activity seen with TPA stimulation.
Taken together, these data demonstrate that PE regulate
NCC activity by enhancing the ubiquitination of NCC, trigger-
ing its endocytosis, and thereby reducing its activity. Our data
show that this is accomplished by PE-mediated activation of
RasGRP1, triggering Ras, MEK1/2, and ERK1/2 MAPK acti-
vation. This ERK1/2 MAPK activation then leads to enhanced
ubiquitination of NCC. The increased ubiquitinated NCC leads
to increased endocytosis of NCC and decreased cell surface
expression, ultimately leading to decreased NCC activity.
DISCUSSION
PE-mediated ERK1/2 activation almost completely sup-
presses NCC activity as measured by 22Na studies, accom-
panied by an 70% reduction in surface expression as mea-
sured by biotinylation (12). This finding was echoed by
immunocytochemical staining and confocal microscopy of
MDCK-FLAG NCC cells showing decreased apical cell sur-
face expression with exposure to TPA (Fig. 1). In contrast to
WNK4’s reported effects on NCC, the PE do not appear to
affecting forward trafficking of the cotransporter (3, 9, 33)
Additionally, this work demonstrates that ERK1/2 MAPK
activation by a PE/RasGRP1-mediated pathway triggers endo-
cytosis of NCC. Tracking internalized NCC after PE treatment
using biotinylation and subsequent treatment with MesNa
showed a marked increase in internalized NCC in response to
PE treatment, indicating endocytosis. The dynamin depen-
dence of this finding was confirmed by introducing the domi-
nant-negative dynamin mutant K44A into the system, which
inhibited that change in NCC surface expression, indicating
that PE’s effect was via dynamin-dependent endocytosis of
NCC. Using BFA to inhibit Golgi transport does not inhibit the
effect of PE on surface expression, indicating that PE work
primarily by stimulating endocytosis and not by affecting
forward trafficking. To our knowledge, this is the first report of
endocytosis of NCC.
In our mDCT cell model, NCC appears to be ubiquitinated
and run as two ubiquitinated species (Fig. 4A). This is the first
report of ubiquitination of NCC. Inhibition of ubiquitination
with an E1 enzyme inhibitor eliminates the top band. This
suggests that NCC may be constitutively ubiquitinated, with a
second ubiquitination event mediated by PE stimulation. It is
unclear whether this ubiquitination event represents short-
chain polyubiquitination at the previous site or multiubiquiti-
nation at different sites, and this issue merits further study. Of
note, while baseline ubiquitination is observed in the mDCT
model, the transfected MDCK model does not appear to
demonstrate significant baseline ubiquitination. This may be
due to an alteration in baseline ubiquitination, due to a number
of potential mechanisms. In ENaC, alterations in baseline
ubiquitination were seen depending on the level of expression
of the E3 ligase Nedd4–2 (44). These models may simply have
varying expressions of the relevant E3 ligase, or for that matter
a deubiquitinating enzyme (DUB), resulting in the differences
in baseline ubiquitination. Determining the mechanism behind
these differences merits future study.
In a series of whole animal studies conducted by Sandberg
et al. (23, 24), NCC was shown by immunoelectron micros-
copy to reside in an apical (cell surface expressed) pool as well
as in subapical vesicles. NCC appeared to redistribute within
these pools in response to the administration of an angiotensin-
converting enzyme inhibitor or angiotensin II infusion. These
studies, however, could not distinguish between a decrease in
forwarding trafficking and insertion of NCC in the plasma
Fig. 7. Inhibition of ubiquitination prevents a TPA-mediated decrease in NCC
activity. mDCT cells were grown to confluence, treated with UBEI-41 (U) or
vehicle for 15 min, and then treated with 100 nM TPA (T) or vehicle (DMSO,
C) for 15 min. A: cells treated as described were labeled with biotin at 4°C.
Biotinylated (cell surface) proteins were recovered using streptavidin-agarose
and immunoblotted for NCC. NC, no biotin control. Accompanying densitom-
etry is shown (n  4). *P  0.05. B: cells treated as above were subsequently
incubated in uptake medium with 22Na and either vehicle or 1 mM metola-
zone. Radioactive uptake was determined as in MATERIALS AND METHODS.
Thiazide-sensitive uptake was calculated as the difference in radiotracer uptake
between the metolazone-containing and the metolazone-free groups. TU,
TPAUBEI-41 (n  6). *P  0.01.
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membrane or an increase in endocytosis of NCC from the
plasma membrane (23, 24). Experiments using the Xenopus
laevis expression system to coexpress WNK4 and enhanced
green fluorescent protein-NCC have demonstrated reduced
NCC cell surface expression in the presence of WNK4, a
kinase associated with the form of genetic hypertension known
as FHHt (40, 41). In this case, further studies demonstrated that
the addition of a K44A dynamin-dominant negative did not
affect WNK4 inhibition of NCC cell surface expression. This
ultimately led to work using inhibitors of Golgi transport and
lysosomal degradation to show that WNK4 likely impacted
NCC surface expression by impeding forward trafficking to the
cell surface and enhancing lysosomal degradation (3, 9, 33).
While endocytosis of NCC has not been previously demon-
strated, there are numerous examples of transport protein
regulation via dynamin-dependent endocytosis, and ERK1/2
MAPK has also been shown to mediate changes in surface
expression of ion transport proteins (10, 29, 35, 36, 43). We
previously demonstrated that the RasGRP1-ERK1/2 MAPK
pathway was essential for decreasing NCC surface expression
and activity associated with DAG/PE (12). The PE TPA, a
functional analog of DAG, activates RasGRP1, which in turn
activates the small G protein Ras. Ras goes on to activate a
cascade involving Raf and MEK1/2, which then phosphory-
lates ERK1/2 MAPK, activating it. This cascade represents a
novel pathway for endocytosis-mediated regulation of NCC.
Certain heterotrimeric G proteins activate phospholipase C,
releasing DAG and inositol 1,4,5-trisphosphate from the cell
membrane, making G-coupled protein receptors expressed in
the DCT such as the calcium-sensing receptor a likely possi-
bility. In addition, any hormones with receptors in the DCT and
effects on ERK1/2 are likely candidate hormones. Possible
hormonal targets therefore include epidermal growth factor and
aldosterone.
Here, we investigated a potential role of ubiquitin in the
regulation of NCC via the ERK1/2 MAPK pathway and dem-
onstrated that in both mDCT and transfected MDCK cells
expressing FLAG-NCC, TPA administration causes a marked
increase in ubiquitination (Fig. 5). This increase in ubiquitina-
tion is of a similar time course to the increase in internalized
NCC as measured by the biotinylation/MesNa assay, suggest-
ing a possible direct relationship between these findings (Fig.
5). We further investigated the role of ERK1/2 MAPK in the
ubiquitination of NCC and showed that inhibiting ERK1/2
activation by either blocking MEK1/2 or gene silencing Ras-
GRP1 prevented an increase in ubiquitinated NCC by TPA
(Fig. 6). This clearly demonstrates that ERK1/2 phosphoryla-
tion is required for ubiquitination of NCC in a pathway starting
with DAG/PE activation of RasGRP1.
By inhibiting ubiquitination of NCC via an E1 inhibitor, we
were able to directly assess the role of ubiquitination in
triggering endocytosis and therefore decreasing NCC activity
in this system. Prevention of NCC ubiquitination eliminated
any change in NCC surface expression with PE treatment (Fig.
7). ERK1/2 activation by TPA, however, remained intact,
indicating that ERK1/2 MAPK alone is not sufficient for the
usual observed DAG/PE effect on NCC (Fig. 7).
Ubiquitination of NCC has not been previously described,
but ubiquitination has been demonstrated to play a role in the
regulation of other transport proteins (11, 14, 15, 37). It is a
highly conserved 76-amino acid polypeptide with an ever-
growing list of cellular functions (32). Ubiquitin is covalently
linked to its substrate by an isopeptide bond between its
C-terminal glycine and the ε-amino group of lysine residues.
This occurs via the actions of three enzymes. First, an ubiq-
uitin-activating enzyme (E1) binds to ubiquitin before transfer
to an ubiquitin-conjugating enzyme (E2). Next, the ubiquitin is
transferred to the substrate protein with the aid of an ubiquitin
ligase (E3), either by directly binding to the substrate from E2
in a reaction catalyzed by E3 or by forming an intermediate
complex with E3.
In this system, the increase in NCC ubiquitination appears
tied to ERK1/2 MAPK activation, but the actual mechanism by
which this occurs is unclear, with a number of plausible
mechanisms existing. These include direct phosphorylation of
NCC (as is the case with ERK1/2 and ENaC), stimulation of an
E3 ligase (described in many systems, such as regulation of the
tumor suppressor protein p53), or inhibition of a DUB (1a, 2,
15, 20, 26, 28, 30, 31, 38). In addition to these possibilities,
ERK1/2 enhancement of ubiquitination could be a multiple-
step process, with ERK1/2 activating a second mediator which
then acts on NCC, a ubiquitin ligase, or other regulatory
protein. Of these prospective pathways, the simplest would be
direct phosphorylation of NCC by ERK1/2, thereby enhancing
the action of an E3 ligase and thereby enhancing ubiquitina-
tion. NCC, however, contains no traditional consensus sites for
ERK1/2 MAPK phosphorylation. While noncanonical phos-
phorylation sites certainly are possible and the other mecha-
nisms have not been explicitly demonstrated in ERK1/2
MAPK, this raises the likelihood that ERK1/2 may act via a
different mechanism (25). Potential pathways involving E3
ligases, deubiquitinating enzymes, or other mediators provide
attractive possible targets, and further work is merited to single
out the possible effectors from the hundreds of E3 ligases,
dozens of DUBs, and countless other kinases.
The lysine(s) on NCC to which ubiquitin attaches are un-
known, and ubiquitination at these sites can carry unique
regulatory implications (16). Similarly, the pattern of ubiquiti-
nation, be it monoubiquitination, polyubiquitination, or mul-
tiubiquitination, can play a key determinant in regulation. For
instance, monoubiquitination, ubiquitination at a single site by
a single ubiquitin, can signal endocytosis and lysosomal deg-
radation, with epidermal growth factor receptor and other
tyrosine kinase receptors being good examples (17). Polyubiq-
uitination, where a ubiquitin attached to a target protein is itself
ubiquitinated at one of its own lysines, often forming long
polymerized chains of ubiquitin molecules, is well studied. The
sites at which ubiquitin polymerizes have been correlated with
the degradation pathway for the ubiquitinated protein (6, 22).
Multiubiquitination, or monoubiquitination at multiple sites on
the target protein, has also been described in other systems and
can serve as a signal for endocytosis (1a, 15, 15a, 20, 26, 28,
31, 38).
In this study, we have demonstrated that NCC is endocy-
tosed in response to PE administration. Furthermore, we de-
scribe that NCC is ubiquitinated and that this ubiquitination is
essential for the regulation of NCC by PE. Activation of
ERK1/2 MAPK by a pathway involving RasGRP1, Ras, Raf,
and MEK1/2 is essential for DAG/PE-mediated ubiquitination
to occur. This work represents the first description of endocy-
tosis of NCC. It is also the first report of ubiquitination of this
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cotransporter, and future study is warranted to further explore
this means of NCC regulation.
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